Cellular Dynamics Goes Public
The IPO would raise $47 million if the underwriters exercise their option to purchase additional shares. Shares fell 12.1% the first day and were down 17.2% at the end of the month (see page4).
Madison, WI 7/24/13; Madison, WI 7/30/13—Cellular Dynamics International, a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, has completed its IPO (see IBO 6/15/13, 7/15/13). The company offered 3,846,000 shares of common stock at a price of $12 per share, raising approximately $43 million after deducting underwriting discounts and commissions. The shares began trading on the NASDAQ Global Market on July 25. Underwriters have a 30-day option to purchase up to an additional 576,000 shares of common stock.
